Journals / İstanbul Journal of Pharmacy / 2020 / Cilt: 50 - Sayı: 2

Evaluation of excipients effects on the impurity profile of lyophilized hydroxocobalamin formulation

Pages
89–94
Publication Date
2020-08-27
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The impurity problem of lyophilized hydroxocobalamin formulation was optimized with lactose monohydrate and lactose monohydrate + EDTA combination.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Aims: The aim of the research work was to compare excipient effects and develop a stable pharmaceutical product in the form of lyophilized powder.
📊
Key Findings & Data:Mannitol, lactose monohydrate, EDTA and glycine are widely used in pharmaceutical formulations and food products.
💡
Conclusion & Impact:The impurity problem of lyophilized hydroxocobalamin formulation was optimized with lactose monohydrate and lactose monohydrate + EDTA combination.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Drug formulation · excipient · lyophilization

Abstract

Background and Aims: The aim of the research work was to compare excipient effects and develop a stable pharmaceutical product in the form of lyophilized powder. Mannitol, lactose monohydrate, EDTA and glycine are widely used in pharmaceutical formulations and food products. Methods: The production method consists of mainly four parts: raw material weighing process, preparation of bulk solutions, lyophilization and analytical determination. A total of five formulations were prepared and lyophilized to the stability study. To improve the stability of hydroxocobalamin formulations (F1-F5), they were evaluated with different excipients (mannitol, lactose monohydrate, EDTA and glycine) during the stability period. Stability studies were performed to check impurity and assay of hydroxocobalamin. Results: The rate of impurity and assay results were compared to F1-F5 formulations. As a result of impurity and assay analysis for F3 and F4, the formulations were found to be within limit. Both of them were determined to the best formulations for impurity of hydroxocobalamin. Conclusion: The research proposes a new stable formulation and proper storage conditions for lyophilized hydroxocobalamin parenteral solutions. The impurity problem of lyophilized hydroxocobalamin formulation was optimized with lactose monohydrate and lactose monohydrate + EDTA combination.

🔖

Cite This Article

GÜN, G., KARABACAK, İ., GÜLELİ, M., KIZILOK, Ş., SEMİZ, S., ÖZBEK, M., ÖZAKIN, S. (2020). Evaluation of excipients effects on the impurity profile of lyophilized hydroxocobalamin formulation. İstanbul Journal of Pharmacy, Cilt: 50 - Sayı: 2, 89–94. https://ajindex.com/articles/88770

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Ahmad, I., Ansari, I. A., & Ismail, T. (2003). Effect of nicotinamide on the photolysis of cyanocobalamin in aqueous solution. Journal of Pharmaceutical and Biomedical Analysis, 31, 369–374.
  2. Ahmad, I., Qadeer, K., Zahid, S., Sheraz, M. A., Ismail, T., Hussain, W., & Ansari, I. A. (2014). Effect of ascorbic acid on the degradation of cyanocobalamin and hydroxocobalamin in aqueous solution: A kinetic study. American Association of Pharmaceutical Scientists, 15, 1324–1333.
  3. Ahmad, I., Ahmed, S., Anwar, Z., Sheraz, M. A., & Sikorski, M. (2016). Photostability and photostabilization of drugs and drug products. International Journal of Photoenergy, 1,1–19.
  4. Atici, B., & Karlıga, B. (2015). Identification, synthesis and characterization of process related impurities of benidipine hydrochloride, stress-testing/stability studies and HPLC/UPLC method validations. Journal of Pharmaceutical Analysis, 4, 256-268.
  5. Atici, B., Yazar, Y., Agtas, C., Ridvanoglu, N., & Karlıga, B. (2017). Development and validation of stability indicating HPLC methods for related substances and assay analyses of amoxicillin and potassium clavulanate mixtures. Journal of Pharmaceutical and Biomedical Analysis, 136, 1–9.
  6. Baheti, A., Kumar, L., & Bansal, A. K. (2010). Excipients used in lyophilization of small molecules. Journal of Excipients and Food Chemistry, 1, 41–54.
  7. Cappola, M. L. (2000). Freeze-Drying Concepts. The Basics, in Mc- Nally EJ (ed): Protein formulation and delivery, (pp 159-199),
  8. Marcel Dekker, New York. Carstensen, J. T., Osadca, M., & Rubin, S. H. (1969). Degradation mechanisms for water-soluble drugs in solid dosage forms. Journal of Pharmaceutical Sciences, 58, 549–553. • DRUGBANK website, retrieved from https://www.drugbank.ca/ drugs/DB00200. Dubost, D. C., Kaufman, M. J., Zimmerman, J. A., Bogusky, M. J., Coddington, A. B., & Pitzenberger, S. M. (1996). Characterization of a solid state reaction product from a lyophilized formulation of a cyclic heptapeptide. A novel example of an excipient-induced oxidation. Pharmaceutical Research, 13, 1811–1814.
  9. Edelmann, M., Chamlagain, B., Santin, M., Kariluoto, S., & Piironen, V. (2016). Stability of added and in situ-produced vitamin B12 in breadmaking. Food Chemistry, 204, 21–28.
  10. El-dawy, M. A., Mabrouk, M. M., & El-Barbary, F. A. (2002). Liquid chromatographic determination of fluoxetine. Journal of Pharmaceutical and Biomedical Analysis, 3, 561–571.
  11. Fatima, N., Mamatha, T., Qureshi, H. K., Anitha, N., & Rao, J. V. (2011). Drug-e